Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

91952 ARTíCULOS , VIENDO DEL 83236 AL 83250

PUBMED

Myricetin reduces toxic level of CAG repeats RNA in Huntington's Disease (HD) and Spino Cerebellar Ataxia (SCAs).

Khan E, Tawani A, Mishra SK, Verma AK, Upadhyay A, Kumar M, Sandhir R, Mishra A, Kumar A.

ACS Chem Biol. 2017 Nov 27. doi: 10.1021/acschembio.7b00699. [Epub ahead of print]

0

0

0

PUBMED

Mutant huntingtin protein expression and blood-spinal cord barrier dysfunction in Huntington's disease.

Sciacca G, Cicchetti F.

Ann Neurol. 2017 Nov 24. doi: 10.1002/ana.25107. [Epub ahead of print]

0

0

0

PUBMED

Spatiotemporal Proteomic Profiling of Huntington's Disease Inclusions Reveals Widespread Loss of Protein Function.

Hosp F, Gutiérrez-Ángel S, Schaefer MH, Cox J, Meissner F, Hipp MS, Hartl FU, Klein R, Dudanova I, Mann M.

Cell Rep. 2017 Nov 21;21(8):2291-2303. doi: 10.1016/j.celrep.2017.10.097.

0

0

0

PUBMED

Altered Aconitase 2 Activity in Huntington's Disease Peripheral Blood Cells and Mouse Model Striatum.

Chen CM, Wu YR, Chang KH.

Int J Mol Sci. 2017 Nov 21;18(11). pii: E2480. doi: 10.3390/ijms18112480.

0

0

0

PUBMED

Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models.

Yu M, Fu Y, Liang Y, Song H, Yao Y, Wu P, Yao Y, Pan Y, Wen X, Ma L, Hexige S, Ding Y, Luo S, Lu B.

Cell Res. 2017 Dec;27(12):1441-1465. doi: 10.1038/cr.2017.113. Epub 2017 Oct 13.

0

0

0

PUBMED

The views of adults with Huntington's disease on assisted dying: A qualitative exploration.

Regan L, Preston NJ, Eccles FJR, Simpson J.

Palliat Med. 2017 Nov 1:269216317741850. doi: 10.1177/0269216317741850. [Epub ahead of print]

0

0

0

PUBMED

Co-occurrence of mixed proteinopathies in late-stage Huntington's disease.

St-Amour I, Turgeon A, Goupil C, Planel E, Hébert SS.

Acta Neuropathol. 2017 Nov 13. doi: 10.1007/s00401-017-1786-7. [Epub ahead of print]

0

0

0

PUBMED

Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.

Coppen EM, Jacobs M, van den Berg-Huysmans AA, van der Grond J, Roos RAC.

Parkinsonism Relat Disord. 2017 Nov 2. pii: S1353-8020(17)30424-8. doi: 10.1016/j.parkreldis.2017.11.001. [Epub ahead of print]

0

0

0

PUBMED

Molecular insights into cortico-striatal miscommunications in Huntington's disease.

Veldman MB, Yang XW.

Curr Opin Neurobiol. 2017 Nov 7;48:79-89. doi: 10.1016/j.conb.2017.10.019. [Epub ahead of print] Review.

0

0

0

PUBMED

Towards an Understanding of Energy Impairment in Huntington's Disease Brain.

Dubinsky JM.

J Huntingtons Dis. 2017 Nov 9. doi: 10.3233/JHD-170264. [Epub ahead of print]

0

0

0

PUBMED

Localization of neuroglobin in the brain of R6/2 mouse model of Huntington's disease.

Cardinale A, Fusco FR, Paldino E, Giampà C, Marino M, Nuzzo MT, D'Angelo V, Laurenti D, Straccia G, Fasano D, Sarnataro D, Squillaro T, Paladino S, Melone MAB.

Neurol Sci. 2017 Nov 3. doi: 10.1007/s10072-017-3168-2. [Epub ahead of print]

0

0

0

PUBMED

Predictive testing of minors for Huntington's disease: The UK and Netherlands experiences.

Quarrell OW, Clarke AJ, Compton C, de Die-Smulders CEM, Fryer A, Jenkins S, Lahiri N, MacLeod R, Miedzybrodzka Z, Morrison PJ, Musgrave H, O'Driscoll M, Strong M, van Belzen MJ, Vermeer S, Verschuuren

Am J Med Genet B Neuropsychiatr Genet. 2017 Nov 2. doi: 10.1002/ajmg.b.32582. [Epub ahead of print]

0

0

0

PUBMED

FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington's disease and their derived neural cells.

Liu Y, Qiao F, Leiferman PC, Ross A, Schlenker EH, Wang H.

Hum Mol Genet. 2017 Nov 15;26(22):4416-4428. doi: 10.1093/hmg/ddx327.

0

0

0

PUBMED

The neuroprotective transcription factor ATF5 is decreased and sequestered into polyglutamine inclusions in Huntington's disease.

Hernández IH, Torres-Peraza J, Santos-Galindo M, Ramos-Morón E, Fernández-Fernández MR, Pérez-Álvarez MJ, Miranda-Vizuete A, Lucas JJ.

Acta Neuropathol. 2017 Dec;134(6):839-850. doi: 10.1007/s00401-017-1770-2. Epub 2017 Aug 31.

0

0

0

PUBMED

Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington's disease.

Lee J, Hwang YJ, Kim Y, Lee MY, Hyeon SJ, Lee S, Kim DH, Jang SJ, Im H, Min SJ, Choo H, Pae AN, Kim DJ, Cho KS, Kowall NW, Ryu H.

Acta Neuropathol. 2017 Nov;134(5):729-748. doi: 10.1007/s00401-017-1732-8. Epub 2017 Jun 7.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy